Modern Meadow secures USD130m in Series C funding
Modern Meadow, a specialist in biofabrication, has secured USD130 million in Series C funding and appointed Anna Bakst as Chief Executive Officer. For the past nine years, Modern Meadow’s investment in research and development across material science and biotechnology has paved the way for a future of biobased, sustainable consumer